Related Experiment Video
Updated: Jun 27, 2026

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
Family-Based Study Reveals PDE11A/PDE11A-AS1 Variants in Testicular Germ Cell Tumor Predisposition
Luiza Côrtes1,2, Ana Beatriz Rodrigues1,2, Sara Martoreli Silveira3
1Botucatu Medical School Hospital (HCFMB), São Paulo State University-UNESP, Botucatu 18618-687, SP, Brazil.
Genetic variants in the PDE11A gene are linked to testicular germ cell tumors (TGCT) in young men. These findings highlight the role of inherited genetic factors and PDE11A-AS1 interactions in TGCT predisposition.
Area of Science:
- Genetics
- Molecular Biology
- Oncology
Background:
- Testicular germ cell tumor (TGCT) is a prevalent cancer in young males.
- Family history and twin studies suggest a genetic component in TGCT susceptibility.
- Understanding the genetic basis of TGCT is crucial for risk assessment and prevention.
Purpose of the Study:
- To investigate the genetic factors contributing to TGCT risk.
- To identify specific gene variants associated with TGCT in affected individuals.
- To explore the functional impact of identified variants on gene expression and protein function.
Main Methods:
- Germline exome sequencing was performed on monozygotic twins diagnosed with TGCT and their parents.
- In silico analysis was used to predict RNA-RNA interactions between PDE11A and PDE11A-AS1 transcripts.
- Functional impact of variants on protein structure and stability was assessed.
Main Results:
- Compound heterozygous variants in PDE11A (rs776984134 and rs17400325) were identified in affected twins.
- The rs776984134 variant disrupts splicing, leading to a frameshift.
- The rs17400325 variant may impair PDE11A protein stability and function.
- Variants were located in a region overlapping PDE11A-AS1, suggesting potential post-transcriptional regulation impacts.
- Additional variants in MSH6 and CTU2 were identified as potential disease modifiers.
Conclusions:
- The PDE11A locus plays a contributory role in TGCT predisposition.
- Interactions between PDE11A and its antisense lncRNA PDE11A-AS1 may influence TGCT risk.
- Overlapping sense-antisense genomic regions are biologically relevant in hereditary cancer research.
- TGCT susceptibility likely involves a multigenic contribution.
Related Concept Videos
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Pedigree Analysis
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Principles of Pharmacogenetics: Types of Genetic Variants
